Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
NPJ Precision Oncology|January 24, 2026
Ultrasensitive ctDNA monitoring reveals early predictors of immunotherapy response in advanced cancerDaisuke Nishizaki, Allison Law, Bailiang Li, et al.
Research Square|January 7, 2025
Ultra-sensitive, tumor-informed ctDNA profiling in pembrolizumab-treated esophagogastric cancer patients predicts clinical responsesAndrew B Nixon, Fábio C P Navarro, Katherine I Zhou, et al.
Scientific Reports|March 24, 2026
Monitoring treatment response using an ultra-sensitive ctDNA assay in advanced esophagogastric cancer patientsAndrew B Nixon, Fábio C P Navarro, Katherine I Zhou, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 3, 2021
Prediction of Immunotherapy Response in Melanoma through Combined Modeling of Neoantigen Burden and Immune-Related Resistance MechanismsCharles W Abbott, Sean M Boyle, Rachel Marty Pyke, et al.
JAMA Oncology|June 25, 2026
Neoadjuvant Paclitaxel, Trastuzumab, and Pertuzumab for Stage II to III, ERBB2-Positive Breast Cancer: A Secondary Analysis of the DAPHNe TrialPaolo Tarantino, Tianyu Li, Esther Ritah Ogayo, et al.
Nature Medicine|January 13, 2025
Ultrasensitive ctDNA detection for preoperative disease stratification in early-stage lung adenocarcinomaJames R M Black, Gabor Bartha, Charles W Abbott, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 10, 2026
The Pathologic Response Evaluation and Detection in Circulating Tumor-DNA Study: Ultrasensitive Circulating Tumor-DNA Assessment of Breast Cancer Minimal Residual DiseaseNatasha B Hunter, Heather A Parsons, Leslie Cope, et al.
Cell|November 8, 2025
Longitudinal ultrasensitive ctDNA monitoring for high-resolution lung cancer risk predictionJames R M Black, Takahiro Karasaki, Charles W Abbott, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 16, 2025
Broad Utility of Ultrasensitive Analysis of ctDNA Dynamics across Solid Tumors Treated with ImmunotherapyElena Garralda, Charles Abbott, Alma Calahorro, et al.
Nature Communications|July 9, 2024
Circulating KRAS G12D but not G12V is associated with survival in metastatic pancreatic ductal adenocarcinomaJacob E Till, Lee McDaniel, Changgee Chang, et al.
Pageof 2